TP53 and diffuse midline glioma: The second patient with diffuse midline glioma was found to have mutations in histone H3.3 subtype (K27M), BCORL1 truncation mutation, and TP53 mutation within a highly conserved arginine location within the DNA binding domain to a hydrophobic leucine.